SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is experiencing significant volatility driven by reports of potential diplomatic shifts regarding the Iran conflict, sparking intense debate among traders over whether these developments signal a genuine de-escalation or just another short-term market manipulation. Community sentiment remains deeply polarized, with many market participants expressing skepticism toward overnight price action and warning of a potential 'pump and dump' as concerns persist over energy supply chains and the geopolitical implications of the Strait of Hormuz remaining closed.

Invesco QQQ Trust Series 1 - Units of beneficial interest

QQQ is experiencing intense volatility as investors react to the escalating geopolitical conflict in the Middle East and reports suggesting a shift in U.S. military objectives. Market participants are actively debating the potential for a snapback rally versus further downside, with sentiment heavily influenced by concerns over oil prices and skepticism regarding official statements.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors grapple with a significant technical correction and heightened geopolitical uncertainty surrounding the conflict in the Middle East. While many market participants remain focused on long-term AI fundamentals and discounted valuation metrics, debate continues regarding whether aggressive institutional selling signals a local bottom or the start of a broader cyclical decline.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is currently a focal point for traders tracking the rapid escalation of geopolitical tensions in the Middle East and the resulting surge in global oil prices. The community is actively debating the potential for a massive short squeeze, driven by supply chain disruptions, reports of major energy infrastructure damage, and widespread skepticism regarding government-led diplomatic negotiations.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

Market volatility is being driven by conflicting headlines regarding a potential ceasefire and diplomatic negotiations with Iran, keeping traders on edge as they weigh ongoing military maneuvers against optimistic headlines. Community sentiment is deeply divided, with many participants expressing skepticism over the legitimacy of news reports and actively debating whether current price action represents a genuine reversal or another tactical trap.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors grapple with escalating tensions in the Middle East and conflicting reports regarding potential diplomatic resolutions. The community is actively debating whether ongoing military posturing and threats of infrastructure strikes signal a prolonged energy supply shock or if market volatility is being driven by speculative trading and political rhetoric.

Spdr Dow Jones Industrial Average ETF Trust - Units of undivided interest in DIAMONDS Trust Series 1

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of intense market volatility, driven by heightened geopolitical tensions in the Middle East and conflicting reports regarding potential ceasefires. Retail traders remain deeply divided, with many debating the impact of energy price fluctuations on broader indices while others speculate on the potential for aggressive short squeezes amid extreme market sentiment.

Maul Coin

Maul Coin is trending as the community rallies behind the creator's mission to build an organic, transparent project that resists typical whale manipulation. Investors are actively discussing the coin's growth potential, coordinating to get it listed on charting platforms, and emphasizing a 'hold' strategy to achieve long-term appreciation.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DebtReliefBot (DRB) is generating significant community buzz due to its unique association with the Grok AI ecosystem and its integration with the Bankr protocol on the Base chain. Investors are highlighting the project's perceived undervaluation and AI-driven origins, leading to active social media discussion about its potential as a sleeper opportunity.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as market sentiment shifts to recognize its significant role as a primary beneficiary of the global LNG supply shortage caused by infrastructure damage in the Middle East. The community is actively discussing a flurry of analyst upgrades, the company's aggressive capacity expansion, and the long-term structural demand for reliable energy, while closely monitoring ongoing geopolitical tensions and potential settlement news as key catalysts for further growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Journey Medical (NASDAQ:DERM - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by...

HC Wainwright Forecasts Journey Medical Q1 Earnings

Journey Medical Corporation (NASDAQ:DERM - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Journey Medical in a research report issued to clients...

Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Journey Medical (DERM) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HC Wainwright Reaffirms Buy Rating for Journey Medical (NASDAQ:DERM)

HC Wainwright restated a "buy" rating and set a $13.00 target price on shares of Journey Medical in a research report on Thursday...

Journey Medical Q4 Earnings Call Highlights

Journey Medical (NASDAQ:DERM) executives highlighted a milestone 2025 marked by the commercial launch of EMROSI, an internally developed oral treatment for the inflammatory lesions of rosacea, and...

Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday

Journey Medical (NASDAQ:DERM) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 25. (View Earnings Report at...

Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been given an average recommendation of "Hold" by the five ratings firms that are presently covering the stock, MarketBeat.com reports...

Journey Medical (NASDAQ:DERM) Shares Down 3.5% - What's Next?

Journey Medical (NASDAQ:DERM) Shares Down 3.5% - Here's What Happened...

Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are currently covering the company, MarketBeat.com reports...

Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been given an average rating of "Hold" by the five brokerages that are currently covering the company, MarketBeat.com reports. One...

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Current Price	$4.39
Prev Close	$4.58
Open	$4.57
Dividend Yield	0.00%
50-Day Moving Average	$7.86
Beta	0.70
Avg. Volume	112,832.29
PE Ratio	-9.11

52-Week High	$9.56
52-Week Low	$4.31
Market Capitalization	$152.15M
EPS (Annual)	-$0.4666
Price to Book	3.74
Revenue Per Employee	$1.07M

DERM
Journey Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DERM News

DERMJourney Medical Corp